Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis

Nature Medicine

Volumn 4, Issue 2, 1998, Pages 187-193

  Rivera Quiñones, Cynthia ^a   McGavern, Dorian ^a   Schmelzer, James D ^a   Hunter, Samuel F ^a   Low, Phillip A ^a   Rodriguez, Moses ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; EVOKED MUSCLE RESPONSE; IMMUNE RESPONSE; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NERVE FIBER; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALS; AXONS; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; EVOKED POTENTIALS, MOTOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVOUS SYSTEM DISEASES; SODIUM CHANNELS;

EID: 0345432117     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0298-187     Document Type: Article

References (28)

1. Rodriguez, M., Oleszak, E. & Leibowitz, J. Theiler's murine encephalomyelitis: A model of demyelination and persistence of virus. Crit. Rev. Immunol. 7, 325-365 (1987).
2. 2-microglobulin-deficient mice. J. Virol. 67, 589-592 (1993).
3. Pullen, L.C., Miller, S.D., Dal Canto, M.C. & Kim, B.S. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23, 2287-2293 (1993).
4. 2-microglobulin. J. Immunol. 151, 266-276 (1993).
5. Njenga, M.K., et al. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 70, 1729-1737 (1996).
6. Rodriguez, M., Leibowitz, J. & David, C.S. Susceptibility to Theiler's virus-induced demyelination: Mapping of the gene within the H-2D region. J. Exp. Med. 163, 620-631 (1986).
7. Rodriguez, M. & David, C.S. Demyelination induced by Theiler's virus: Influence of the H-2 haplotype. J. Immunol. 135, 2145-2148 (1985).
8. Foster, R.E., Whalen, C.C. & Waxman, S.G. Reorganization of the axon membrane in demyelinated peripheral nerve fibers: Morphological evidence. Science 210, 661-663 (1980).
9. Bostock, H., Hall, S.M. & Smith, K.J. Demyelinated axons can form 'nodes' prior to remyelination. J. Physiol. (Lond.) 308, 21P-23P (1980).
10. Smith, K.J., Bostock, H. & Hall, S.M. Saltatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline. J. Neurol. Sci. 54, 13-31 (1982).
11. Waxman, S.G. Demyelination in spinal cord injury and multiple sclerosis: What can we do to enhance functional recovery? J. Neurotraurma 9, S105-S117 (1992).
12. Rodriguez, M. & Sriram, S. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J. Immunol. 140, 2950-2955 (1988).
13. 2 microglobulin-deficient mice following virus-induced demyelination. J. Neurosci. 15, 8345-8352 (1995).
14. Miller, D.J., Njenga, M.K., Murray, P.D., Leibowitz, J. & Rodriguez, M. A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination. Int. Immunol. 8, 131-141 (1996).
15. Brinkmeier, H., Kaspar, A., Wietholter, H. & Rudel R. Interleukin-2 inhibits sodium currents in human muscle cells. Pfluegers Arch. 420, 621-623 (19??).
16. Black, J.A., Felts, P., Smith, K.J., Kocksis, J.D. & Waxman, S.G. Distribution of sodium channels in chronically demyelinated spinal cord axons: Immuno-structural localization and electrophysiological observations. Brain Res. 544, 59-70 (1991).
17. 7. McDonald, W.I. & Sears, T.A. Effect of demyelination on conduction in the central nervous system. Brain 93, 583-598 (1970).
18. Filippi, M., et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: A follow-up study. Neurology 45, 255-260 (1995).
19. Gilbert, J.J. & Sadler, M. Unsuspected multiple sclerosis. Arch. Neurol. 40, 533-536(1983).
20. Mackay, R.P. & Hirano, A. Forms of benign multiple sclerosis: Report of two "clinically silent" cases discovered at autopsy. Arch. Neurol. 17, 588-600 (1967).
21. Moll, C., Mourre, C., Lazdunsky, M. & Ulrich, J. Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res. 556, 311-316 (1991).
22. Hauser, S.L., et al. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19, 578-587 (1986).
23. Sibley, W.A., Bamford, C.R. & Clark, K. Clinical viral infections and multiple sclerosis. Lancet 1, 1313-1315 (1985).
24. The IFNβ Multiple Sclerosis Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double blind, placebo-controlled trial. Neurology 43, 655-661 (1993).
25. Iuliano, B.A., Schmelzer, J.D., Thiemann, R.L., Low, P.A. & Rodriguez, M. Motor and somatosensory-evoked potentials in mice infected with Theiler's murine encephalomyelitis virus. J. Neurol. Sci. 123, 186-194 (1994).
26. + channels and node of Ranvier formation in remyelinating axons. J. Neurosci. 15, 492-503 (1995).
27. + channels: Presynaptic localization in cerebellum and hippocampus of neurological mutant mice. Brain Res. 533, 196-202 (1990).
28. Robb, R.A., et al. ANALYZE: A comprehensive, operator-interactive software package for multidimensional medical image display and analysis. Comput. Med. Imag. Graphics 13, 433-454 (1989).